Cassava Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1999
Net Income	-97.22	-76.25	-32.39	-6.33	-4.63	-6.56	-11.91	-14.85	-14.15	-12.39	Upgrade
Depreciation & Amortization	1.53	1.3	0.53	0.02	0.06	0.07	0.07	0.06	0.05	0.02	Upgrade
Share-Based Compensation	4.59	2.07	1.76	0.99	1.3	2.39	2.97	4.33	3.46	3.76	Upgrade
Other Operating Activities	9.08	-4.64	-0.1	-0.06	0.76	-0.67	0.63	-1.78	1.59	-0.94	Upgrade
Operating Cash Flow	-82.03	-77.51	-30.2	-5.38	-2.51	-4.77	-8.24	-12.23	-9.05	-9.55	Upgrade
Capital Expenditures	-0.41	-2.71	-22.21	0.36	-0.02	0	0	-0.08	-0.2	-0.08	Upgrade
Change in Investments	0	0	0	0	0	0	2.1	-2.09	0	1.25	Upgrade
Investing Cash Flow	-0.41	-2.71	-22.21	0.36	-0.02	0	2.1	-2.17	-0.19	1.17	Upgrade
Share Issuance / Repurchase	2.56	47.8	192.34	75.45	5.87	14.1	0	0	0	0.38	Upgrade
Other Financing Activities	-	-	-	-	-0.06	-	-	-0.28	-0.05	-	Upgrade
Financing Cash Flow	2.56	47.8	192.34	75.45	5.81	14.1	0	-0.28	-0.05	0.38	Upgrade
Net Cash Flow	-79.88	-32.42	139.93	70.43	3.27	9.33	-6.14	-14.68	-9.29	-8	Upgrade
Free Cash Flow	-82.44	-80.23	-52.41	-5.02	-2.53	-4.77	-8.24	-12.31	-9.25	-9.63	Upgrade
Free Cash Flow Per Share	-1.97	-2.00	-1.33	-0.19	-0.14	-0.45	-1.26	-1.89	-1.43	-1.49	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).